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Abstrak: Protein pengikat maltosa (MBP) adalah protein pengikat periplasmik yang boleh 
dijumpai di dalam bakteria Gram negatif. MBP terlibat di dalam proses pengangkutan 
maltosa serta kemotaksis bakteria; MBP mengikat pada maltosa serta maltodekstrin yang 
mempunyai rangkaian linear α(1-4)-glukosilik polimer glukosa dan rangkaian siklodekstrin 
α(1-4)-glukosilik. Semasa protein mengikat pada ligan, perubahan struktur konformasi 
MBP berlaku dari bentuk terbuka ke bentuk tertutup. Pengecaman molekular ini yang 
menyebabkan transduksi pengikatan ligan kepada bentuk fizikal menjadikan MBP calon 
yang sesuai sebagai penderia pendaflour tanpa deria. Di sini, kami akan menerangkan 
bagaimana mutan Strep-tag II MBP dibina untuk dijadikan sebagai penderia pendaflour 
tanpa reagen. Gen malE, yang mengekodkan MBP telah diamplifikasikan. Residu sistina 
telah diperkenalkan melalui proses tapak terarah mutagenesis agar label lekatan tunggal 
pada tapak yang spesifik yang mempunyai kuar pendaflour spesifik-tiol. Fluorofor yang 
sensitif pada persekitaran (IANBD amide) terlekat secara kovalen pada kumpulan tiol yang 
diperkenalkan sebelum ini dan kemudian dianalisa secara deria pendaflour. Mutan MBP 
(D95C) telah ditulenkan (saiz molekular, ~42 kDa). Ukuran pendaflour Strep-tag II–D95C 
yang telah dilabel oleh IANBD di dalam larutan telah menunjukkan perubahan keamatan 
pendaflour yang memberangsangkan (pemalar penguraian Kd 7.6±1.75 µM). Mutan MBP 
berjaya mengekalkan aktiviti pengikatan kepada maltosa dan sesuai dijadikan sebagai 
penderia pendaflour tanpa reagen. 
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Abstract: Maltose-binding protein (MBP) is a periplasmic binding protein found in Gram 
negative bacteria. MBP is involved in maltose transport and bacterial chemotaxis; it binds 
to maltose and maltodextrins comprising α(1-4)-glucosidically linked linear glucose 
polymers and α(1-4)-glucosidically linked cyclodextrins. Upon ligand binding, MBP 
changes its conformation from an open to a closed form. This molecular recognition—
transducing a ligand-binding event into a physical one—renders MBP an ideal candidate 
for biosensor development. Here, we describe the construction of a Strep-tag II mutant 
MBP for reagentless fluorescence sensing. malE, which encodes MBP, was amplified. A 
cysteine residue was introduced by site-directed mutagenesis to ensure a single label 
attachment at a specific site with a thiol-specific fluorescent probe. An environmentally 
sensitive fluorophore (IANBD amide) was covalently attached to the introduced thiol group 
and analysed by fluorescence sensing. The tagged mutant MBP (D95C) was purified 
(molecular size, ~42 kDa). The fluorescence measurements of the IANBD-labelled               
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Strep-tag II–D95C in the solution phase showed an appreciable change in fluorescence 
intensity (dissociation constant, 7.6±1.75 µM). Our mutant MBP retains maltose-binding 
activity and is suitable for reagentless fluorescence sensing.  
 





Fluorescence sensing is a rapidly developing field of technology used for 
detecting natural and synthetic compounds in different media and living cells. 
Reagentless fluorescence biosensors are emerging as a novel form of 
fluorescence biosensors. Their quantification does not change the composition of 
the sensor, unlike enzyme-based competitive assays, in which the analyte is 
consumed (Marvin & Hellinga 1998). Periplasmic binding proteins (PBPs) are 
being extensively studied for applications as reagentless fluorescence biosensors 
because of their general structural form and their conformational changes during 
ligand binding, which can be described as a “Venus flytrap,” wherein the two 
lobes of the protein close on the ligand, completely entrapping it (Hellinga & 
Marvin 1998).  
Maltose-binding protein (MBP) belongs to the PBP superfamily, which is 
found in Gram negative bacteria (Zhou & Cass 1991). MBP is a monomeric 
40,600-Da protein encoded by the malE gene, and it has two distinct globular 
domains separated by a three-strand hinge region (Sharff et al. 1993). Other than 
binding to maltose, MBP can also be manipulated by protein engineering to bind 
to metal ions for environmental biosensor applications (Marvin & Hellinga 2001; 
Shahir 2006). MBP changes its conformation from an open to a closed form upon 
ligand binding. This molecular recognition, which transforms a ligand-binding 
event into a physical one, renders MBP suitable for biosensor development. 
MBP lacks cysteine residues; therefore, a unique thiol group can be 
introduced by oligonucleotide-directed site-specific mutagenesis (Gilardi et al. 
1994). Thiol-specific fluorophores are specific to the thiol group and are sensitive 
to environmental changes. In addition, this type of fluorophore is detected by 
fluorescence sensing of the conformational changes in MBP upon ligand binding. 
This strategy has been used to introduce single fluorophores that respond to 
ligand binding in MBPs (Sohanpal et al. 1993; Gilardi et al. 1994; Marvin & 
Hellinga 2001; De Lorimier et al. 2002; Dattelbaum et al. 2004), ribose-binding 
proteins (Vercillo et al. 2006), glucose-binding proteins (Lyndon et al. 2001), 
glutamine-binding proteins (De Lorimier et al. 2002), and sulfate-binding proteins 
(Shrestha et al. 2002). Many types of thiol-reactive fluorophores have been used 
in PBP fluorescence sensor studies to detect ligand binding in PBPs. Owing to its 
consistent fluorescence response, 4-[N-(2-(Iodoacetoxy)ethyl)-N-methylamino]-7-
nitrobenz-2oxa-1,3-diazole (IANBD) amide has been found to be a suitable 
fluorophore for covalent attachment to the cysteine residue of recombinant MBP 
(Gilardi et al. 1994; Marvin & Hellinga 1998; Dattelbaum et al. 2004; Shahir 
2006). IANBD amide is an iodoacetamide that forms a thioether bond with a 
cysteine residue, and its fluorescence emission is highly sensitive to its solvation 
state (Johnson & Spence 2011). 
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In this study, the fluorophore was attached to the protein at the allosteric 
site of the protein, which is located at position 95, where aspartic acid was 
replaced by cysteine (D95C). The allosteric site in the protein structure is located 
away from the ligand-binding site, and it undergoes a local conformational 
change in concert with ligand binding (De Lorimier et al. 2002). Furthermore, the 
allosteric site has an advantage in that no direct interaction occurs between the 
ligand and the fluorophore; hence, the binding constant is unaffected (Marvin & 
Hellinga 1998). Several mutations of MBP have been induced at the allosteric 
site for potential reagentless fluorescence sensing, and these are D95C, F92C, 
and I329C (Sohanpal et al. 1993; De Lorimier et al. 2002). In this study, D95C 
was chosen because its use has been reported in several studies (Sohanpal                  
et al. 1993; Marvin et al. 1997; Marvin & Hellinga 2001), and the binding affinity 
towards maltose of D95C is often higher than that of other mutations (Marvin & 
Hellinga 2001; Wemmer 2003).  
However, to our knowledge, all of the reported studies describing signal 
transduction by fluorophore-labelled PBPs have been performed without 
attachments to solid supports (Brune et al. 1994; Gilardi et al. 1994; Hellinga & 
Marvin 1998; Marvin & Hellinga 2001). Affinity tags are widely used in 
biotechnology to assist in the purification of recombinant proteins. Strep-tag II 
provides a fitting combination of qualities, including excellent purification with 
good yield and moderate cost compared to other affinity tags, such as the His-tag 
and the GST-tag (Litchy et al. 2005). The mutant MBP protein was fused to an 
affinity tag, Strep-tag II, to aid in its purification and in the application of site-
directed immobilisation of the MBP onto functionalised solid surfaces. This is the 
first report of reagentless fluorescence sensing of maltose to use Strep-tag             
II-fused mutant MBP. Site-directed mutagenesis was performed on a malE 
template fused to Strep-tag II to incorporate a single cysteine at the allosteric site 
of MBP. The cysteine residue of the mutated protein (D95C) was labelled with 
IANBD amide. The response of the labelled mutant MBP to maltose binding was 
monitored by following the changes observed in the fluorescence intensity of the 
probe, and ligand-binding characteristics were also analysed. 
 
 
MATERIALS AND METHODS 
 
Construction of pET-51b (+)-malE Plasmids 
The malE gene was amplified from the pMAL-c4x plasmid using the polymerase 
chain reaction (PCR) with flanking primers designed to introduce a BamHI 
restriction enzyme site before the start codon and a HindIII site before the stop 
codon. The primers (First BASE Laboratories Sdn. Bhd., Sri Kembangan, 
Selangor, Malaysia) used for isolating the malE gene were as follows: forward, 
For_ malE (5’-CCCGGATCCGAAAATCGAAGAAGGTAAACTGGTC-3’), and 
reverse, Rev_ malE (5’-CCCAAGCTTTTAAGTCTGCGCGTCTTTCAGGCG-3’). A 
30-cycle PCR program was used, with the pMAL-c4x plasmid used as the 
template and primers and Pfu polymerase added to the reaction mix (Fermentas, 
Massachusetts, USA). The cycle conditions were 95°C for 2 min, followed by 30 
amplification cycles of 95°C for 30s, 55°C for 1 min and 72°C for 2 min and then 
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one final elongation cycle at 72°C for 5 min. Reactions were run on a tris-acetate-
ethylenediamine tetraacetic acid (TAE) 1% agarose gel, and when the presence 
of the gene was verified, the remaining PCR mixture was treated with DpnI 
(Fermentas, Massachusetts, USA) at 37°C for 1 hr to digest the methylated 
template, which was then purified with a PCR Clean-up System (Promega, 
Wisconsin, USA). The purified DNA was digested with BamHI and HindIII 
restriction enzymes (Fermentas, Massachusetts, USA) and ligated using T4 DNA 
ligase into pET-51(b) (Novagen, Darmstadt, Germany), which was digested using 
the same restriction enzymes. The constructed plasmid pET-51b(+)-malE was 
then transformed into E. coli NovaBlue Singles cells (Novagen, Darmstadt, 
Germany), and transformants were selected on Luria Bertani ampicilin (LBA) 
plates using 50 µg/mL ampicillin. 
 
Construction of pET-51b(+)-D95C Plasmids (Mutant MBP Plasmid) 
The MBP mutant plasmid was constructed to contain a single substitution: 
aspartic acid (position 95) was replaced with a cysteine. Site-directed 
mutagenesis was performed using inverse PCR by the Pfu DNA polymerase and 
the malE gene (from pET-51b (+)-malE) used as the template. The primers used 
were as follows: forward, D95C_For (5’-TGCGCAGTACGTTACAACGGC-3’), and 
reverse, D95C_Rev (5’- CATCTGCGGGATGTTCGGCAT-3’), and the reaction 
mix was treated with T4 polynucleotide kinase (Fermentas, Massachusetts, USA) 
prior to use at 37°C for 1 hr. The PCR reaction was performed as follows: one 
cycle at 92°C for 2 min, then 15 cycles at 92°C for 20s, 55°C for 1 min and 68°C 
for 6 min, and then one final cycle at 62°C for 10 min. The plasmid construct was 
then verified, purified, ligated and transformed as described for the pET-51b                  
(+)-malE plasmid construct, above.  
 
Expression of the malE Gene 
The recombinant plasmid was transformed into an expression host, 
BL21(DE3)pLySs (Novagen, Darmstadt, Germany), by heat shock 
transformation. The BL21(DE3)pLySs cells harbouring the recombinant plasmid 
were inoculated into 1 mL of Luria Bertani (LB) broth containing 50 µg/mL 
ampicillin and 34 µg/mL chloramphenicol, which was then incubated overnight at 
37°C with shaking. Then, 10 mL of this overnight culture was inoculated into              
200 mL of fresh LB broth containing both of the antibiotics in addition to 1% (v/v) 
glucose and incubated at 37°C with shaking until the optical density (OD) at                 
600 nm reached ~0.4–0.5. The cells were then induced with 1 mM of isopropyl-β-
D-1-thiogalactopyranoside (IPTG) for 4 hours at 30°C. Finally, the cells were 
harvested by centrifugation at 4,000 rpm for 20 min at 4°C. The supernatant was 
discarded, and the pellet was either immediately lysed or kept at –20°C prior to 
lysis.  
 The cell pellets were lysed using the freeze and thaw method. First, the 
cell pellets were thawed, followed by the addition of sterile distilled water and 
benzonase nuclease. One gram of cell pellet material required 5 mL of sterile 
distilled water, and 25 U of benzonase nuclease was added per 1 mL of sterile 
distilled water. The mixture was then incubated at –20°C in a freezer for 10 to 15 
min or until the mixture had frozen. Then, the mixture was thawed on ice for                  
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30 min until the mixture became liquefied. These freezing and thawing steps 
were repeated three times. The host cells contained pLysS and had relatively 
high levels of T7 lysozyme in the cytoplasm, which made it easier to lyse the cells 
under mild conditions such as the freeze/thaw treatment (Mierendorf et al. 
1994a,b). The mixture was then centrifuged at 16,000 × g for 20 min at 4°C to 
remove insoluble cell debris. The supernatant was kept at –20°C. 
 
Recombinant Protein Purification via Strep-Tag II Affinity Purification 
The crude extracts of wild type MBP protein and its mutant were purified by 
affinity chromatography using a 5 mL pre-packed StrepTrap HP™ column (GE 
Healthcare, Buckinghamshire, UK). Purification was performed using Akta Prime 
Plus (GE Healthcare, Buckinghamshire, UK) with a flow rate of 2 mL/min. The 
columns, buffers and the protein samples were kept on ice during the purification 
process to lessen the degradation of the mutant MBP. Purification of the wild type 
MBP was performed at room temperature because MBP is known to be thermally 
stable in solution at temperatures up to 50°C (Gilardi et al. 1994).   
 First, the Akta Prime Plus system was flushed with filtered deionised 
water prior to purification. The column was then connected to the designated 
tubing by carefully dripping the buffer from the tubes into the column to prevent 
air bubbles. The 5 mL StrepTrap HP™ pre-packed column was washed with 
three column volumes of filtered deionised water before starting the purification 
process. The column was equilibrated and washed with five column volumes of 
binding buffer (20 mM NaPO4, 280 mM NaCl, 6 mM KCl and 10 mM 
ethylenediamine tetraacetic acid [EDTA], pH 7.4). Approximately 20 mL of                    
6 mg/mL crude lysate (pre-filtered through a 0.45 µm nylon membrane) was 
loaded into the StrepTrap™ Hp column with a flow rate of 2 mL/min. The column 
was washed with eight column volumes of binding buffer. Next, elution was 
performed using three column volumes of the same binding buffer plus 2.5 mM                 
d-desthiobiotin. The elution profile was monitored by measuring OD at 280 nm, 
and fractions were subsequently analysed by SDS PAGE. 
 
Ultrafiltration of Purified Protein 
The fractions containing Strep-tag II MBP and Strep-Tag II D95C were desalted 
and buffer-exchanged against 10 mM potassium phosphate buffer, pH 7.4, using 
a 20 mL Vivaspin concentrator (10 kDa molecular weight cut-off [MWCO] 
membrane, Sartorius Stedim, Goettingen, Germany). Prior to use, the Vivaspin 
column was washed by adding 15 mL of 10 mM potassium phosphate buffer, pH 
7.4, and then spun at 4,000 rpm for 10 min. Approximately 5–10 mL of the 
protein solution was added, then buffer was added to make the volume 15 mL, 
and the solution was centrifuged at 4,000 rpm for 5 min. The filtrate was 
decanted, buffer was added to make the volume 15 mL, and the solution was 
centrifuged again as previously described. This step was repeated and the 
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Intrinsic Tryptophan Fluorescence of Strep-Tag II Wild Type MBP 
Intrinsic tryptophan fluorescent measurement was performed on a Perkin-Elmer 
fluorometer LS 55 (Massachusetts, USA) with an excitation wavelength of                  
280 nm. The excitation wavelength was set at 280 nm because the aromatic 
amino acids (i.e.: tryptophan, tyrosine and phenylalanine) absorb light at that 
particular wavelength. The intensity of the fluorescence was recorded on the 
addition of maltose towards the purified tagged wild type MBP in the quartz 
cuvette. Approximately 1.0 mL of 1.0 µM purified tagged wild type MBP in 10 mM 
potassium phosphate buffer, pH 7.4, was prepared. First, an initial fluorescence 
measurement was recorded for the protein solution without added maltose. 
Titrations of aliquots of 1 µL maltose, ranging from 10 µM to 100 µM, were added 
to the 1 mL protein solution. These steps were repeated three times. Prior to use, 
the quartz cuvette was treated with 1 M HCl to remove any contaminating protein 
or maltose. The percent changes in fluorescence intensity that were observed 
with increasing ligand concentrations were calculated, and the data was fitted to 
a single-site binding equation (equation [Eq.] 1). The percent changes (%∆F) 
were calculated by subtracting the average value of the intensity at 0 µM (F0) 
from the average value at i µM (Fi) and then dividing by average intensity value 
F0. 
 
                                    (Eq. 1) 
 
 
where ∆F is the fluorescence intensity change, ∆F max is the maximum attainable 
change in fluorescence intensity, [L] is the concentration of the ligand and Kd is 
the dissociation constant. 
 
Labelling of the D95C Mutant with Fluorophore Probes  
The thiol-reactive fluorophore IANBD amide was chosen to label the tagged 
mutant MBP (D95C). The fluorophore was covalently bound to the thiol group of 
the cysteine residue in the tagged mutant MBP (D95C) protein. Approximately 
4.0 mL of 5.0 µM purified tagged mutant MBP in 10 mM potassium phosphate 
buffer, pH 7.4, was prepared. The protein solution was pre-incubated on ice for 
30 minutes with a 2-fold molar excess of dithiothreitol (DTT) from Fermentas, 
Massachusetts, USA (55 mM stock solution) to reduce intermolecular disulphide 
bonds. A 5-fold molar excess of the fluorophore (10 mM stock solution in dimethyl 
sulfoxide [DMSO]) was added, and the mixture was incubated at room 
temperature for 2 hr in ice, while protected from light, on a rotary shaker. Excess 
fluorophore was removed from the conjugated proteins by diafiltration using a 
Vivaspin concentrator (0.5 mL, 10 kDa MWCO, Sartorius, Goettingen, Germany) 
with 10 mM potassium phosphate buffer in a centrifuge at 4,000 rpm for 10 min. 
Diafiltration was repeated three times. The labelling ratio was determined, and 
the labelled protein was then immediately analysed or stored at 4°C for no more 
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Steady-state Fluorescence Study of the Labelled Mutant Protein 
Fluorescence measurements were performed on a Perkin-Elmer fluorometer LS 
55. The excitation and emission monochromator slit widths were both set at                 
10 nm. The excitation wavelength used was 480 nm. The intensity of 
fluorescence emitted was recorded upon the addition of maltose to the labelled 
tagged mutant MBP (D95C) in the quartz cuvette. The labelled protein was 
diluted to 1 µM in 1 mL potassium phosphate buffer, pH 7.4. An initial fluorescent 
measurement of the protein solution prior to the addition of maltose was 
recorded. Titrations of aliquots of 1 µL maltose, ranging from 10 µM to 100 µM, 
were added to the 1 mL protein solution. These steps were repeated three times. 
Prior to use, the quartz cuvette was treated with 1 M HCl to remove 
contaminating protein and maltose. The percent changes in fluorescence 
intensity with increasing ligand concentrations were calculated and fit to a single-
site binding equation, as stated in Eq. 1, and SigmaPlot® V 11.0 (California, 
USA) software was used to fit and simulate the data. To determine the specificity 
of MBP binding with maltose, glucose was added instead of maltose. Titrations of 
aliquots of 1 µL glucose, ranging from 10 µM to 100 µM, were added from a 
ligand stock solution at an appropriate concentration (10 mM glucose) to the 1 
mL protein solution. Then, the specificity of ligand binding of the mutant MBP with 





Purification of Strep-tagged MBP 
To construct a MBP for fluorescence sensing, the aspartic acid at position 95 of 
MBP was mutated to a cysteine residue (D95C) using site-directed mutagenesis. 
The fluorophore was positioned at a location that was distant from the binding 
pocket but at which ligand binding could be sensed indirectly using an allosteric 
coupling mechanism based on the effect of domain movements (Shahir 2006). 
Strep-tagged wild type MBP and mutant MBP (D95C) were purified using affinity 
chromatography. The elution peak containing Strep-tagged MBP and D95C had 
a high resolution. Pure MBP and D95C proteins were obtained, with both being 
approximately 42 kDa in size. The pooled fractions from the elution peak of D95C 
were buffer exchanged with potassium phosphate buffer to remove excess salt, 
detergent (e.g., DTT), and D-desthiobiotin. The pooled protein was concurrently 
concentrated by buffer exchange. This is shown in Figure 1, where the protein 
band of the buffer-exchanged sample is observed to be thicker than the band of 
the pooled fractions before buffer exchange. This finding is further supported in 
Table 1, which shows that after buffer exchange, the protein concentration is 0.33 
mg/mL, which is about three-fold higher than the protein concentration before 
exchange (0.10 mg/mL). 
 
Intrinsic Tryptophan of Strep-tagged MBP 
The fluorescence of the intrinsic tryptophan of the purified wild type MBP was 
resolved to determine if ligand-binding activity was retained in the presence of 
the tag. Wild type MBP was excited at 280 nm, and the fluorescence emission at 
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340 nm was found to be comparable to the emission wavelength of tyrosine and 
tryptophan in water at neutral pH (304 nm and 353 nm, respectively) (Lakowicz 
1999). From a plot of intensity values against maltose concentrations and 
subsequent fitting to the single-site binding equation, the apparent dissociation 




Figure 1: SDS-PAGE analysis of Strep-Tag II MBP and D95C using coomassie blue 
staining.  
 
Notes: Lane 1 - Fermentas unstained protein molecular weight marker; lane 2 - crude lysate of D95C; 
lane 3 - pooled fractions before buffer exchange; lane 4 - pooled fractions after buffer exchange. 
 
 
Table 1: Purification table. The concentrations of and total protein in the protein samples, 
as determined using protein Bradford assay reagents. 
 








Break cell (crude lysate) 20 1.97 39.40 100.0 
Affinity purification 15 0.10 1.50 3.8 
Ultrafiltration (buffer 
exchange) 5 0.33 1.65 4.2 
 
 

























Figure 2: Maltose-binding curves for the intrinsic tryptophan of wild type MBP and IANBD 
D95C. Data were fitted to the single-site binding equation using SigmaPlot V 11.0.  
 
Fluorescence Sensing for Maltose-binding Ability 
The sulfhydryl group of D95C was individually labelled with a polarity-sensitive 
fluorophore, IANBD amide, and typical fluorophore-to-protein molar ratios were 
observed in the range of 0.8–1.2. The labelled D95C was then analysed by 
fluorescence sensing for its maltose-binding ability at increasing maltose 
concentrations. The extrinsic fluorescence emission of IANBD-labelled D95C was 
also measured, and the results showed that the fluorescence intensity increased 
as the ligand concentration increased. On exciting the labelled D95C at 480 nm, 
the fluorescence emission maximum was blue shifted by ~10 nm of the actual 
emission wavelength for IANBD, which is 530 nm. On adding maltose, there was 
an increase in the fluorescence intensity of up to 40%.  
 The binding curve of the percent changes in fluorescence intensity with 
increasing concentrations of maltose was plotted using SigmaPlot® V 11.0. The 
plot and subsequent fitting to the single-site binding equation (Fig. 2) showed that 
the data fit the single-site binding curve, with an R2 value close to 1 (0.8981). The 
apparent Kd of IANBD-labelled D95C that was obtained from the plot of percent 
changes in fluorescence intensity against maltose concentrations was                 
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According to Litchy et al. (2005), Strep-tag II is the most efficient and the 
cheapest system for affinity purification; furthermore, the affinity of Strep-tag II 
towards StrepTactin is higher. This bioaffinity feature could be manipulated for 
unidirectional immobilisation for further biosensor applications. From the results 
of our intrinsic tryptophan assay of the Strep-tag II of the wild type MBP, its 
apparent Kd value is comparable to the Kd value of 3.5 µM of non-tagged and 
non-labelled MBP that was reported by Miller et al. (1983). Hence, the Strep-tag 
II on wild type MBP does not affect its maltose-binding ability, and the tag at the 
N-terminal did not appear to pose a steric hindrance. These results are similar to 
those in another study where lipase enzyme remained functional with a fused 
Strep-tag II (Hamid et al. 2009). Furthermore, no fluorescence changes were 
observed on adding glucose. MBP can bind to maltose, maltotriose, and                 
α(1-4)-linked higher maltodextrins, but it does not recognise or bind to glucose 
(Spurlino et al. 1991). 
 Exciting the labelled D95C at 480 nm resulted in an increase in 
fluorescence intensity that was in agreement with the results of Dattelbaum et al. 
(2004), where a large increase in fluorescence was observed upon maltose 
titration of IANBD-labelled D95C, and a slight blue shift of approximately 5–6 nm 
occurred before and following the addition of maltose. Furthermore, the plot and 
subsequent fitting to the single-site binding equation indicated that the IANBD-
labelled D95C managed to retain its maltose-binding activity with the covalently 
attached IANBD and with the Strep-tag II attached at the N terminal. Additionally, 
the Kd values that we obtained demonstrate that the affinity of D95C-fused            
Strep-tag II toward maltose is lower than that of the wild type (Kd = 3.5 µM) 
(Marvin & Hellinga 2001). The apparent Kd value that was obtained was much 
higher than the values for IANBD-labelled D95C that were obtained in earlier 
studies (Marvin et al. 1997; Dattelbaum et al. 2004; Shahir 2006). The lower 
affinity obtained in this study could be due to steric hindrance by the Strep-tag II 
at the N terminal, which causes a conformational change during maltose binding.  
In studies by Marvin et al. in 1997, Dattelbaum et al. in 2004, and Shahir 
in 2006, the use of shorter tags, such as His6 (six histidine residues) and biotin-
tag (a 15-amino acid peptide), yielded much lower Kd values compared to                
Strep-tag II–D95C. Strep-tag II has an eight-amino acid tag, with an additional set 
of 14 amino acids serving as a cleavage site (Litchy et al. 2005). Thus, there is 
an extra stretch of 22 amino acids at the N terminal of D95C. It is possible that 
the larger size of the Strep-tag might cause steric hindrance, which may thereby 
lower the affinity of the tagged D95C toward maltose. However, further studies 
are needed to confirm this. 
 No significant increases in fluorescence intensity responses were 
observed upon the addition of increasing concentrations of glucose to the 
labelled protein. The plot of the percent changes in fluorescence intensity data 
against glucose concentrations shows that at a value of 0.0462, the fluorescence 
response does not fit the single binding site curve with an R-squared value 
greater than 1. This suggests that D95C does not bind to glucose because the 
binding site of MBP does not have hydrogen bond acceptors, which leaves the 
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donatable hydrogen of the C4 hydroxyl or the C1 hydroxyl of glucose unpaired if 
the monosaccharide binds to the binding site (Spurlino et al. 1991). Hence, 
tagged D95C still binds specifically to maltose. 
 Furthermore, the fluorescence response observed with maltose-binding 
activity indicates that the mutation site at D95C is heterotropically cooperative 
with respect to the specific binding of maltose (Marvin et al. 1997). Heterotropic 
cooperation implies that the substrate binds to the enzyme at only one site and 
that a different molecule modifies the reaction by binding to an allosteric site 
(Marvin et al. 1997). In this sense, the fluorescence of the conjugated protein with 
the attached fluorophore IANBD is changed in a heterotropically cooperative 
manner with respect to maltose (Marvin et al. 1997). Furthermore, the mutation of 
D95C is at the allosteric site of the maltose-binding site, and the attached 
fluorophore IANBD is appropriately placed within the site such that its 
environment is sufficiently affected by local conformational changes to elicit a 
change in fluorescence (Marvin et al. 1997). Thus, Strep-tag II–fused D95C 
retains its ligand-binding activity and specificity toward maltose.  
 In summary, a reagentless sensing scheme for maltose was designed 
and developed using MBP mutants that allows for site-specific labelling with a 
fluorophore. The detection limit obtained in this study was nearly the same as 
that reported in several other studies. The slight difference might be due to 
possible steric hindrance by the Strep-tag II at the N terminal of the protein. The 
tagged mutant MBP (Strep-tag II–D95C) retained its ligand-binding activity 
toward maltose, but less tightly. Thus, this engineered mutant MBP could be 
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